Norepinephrine (NE) neurons within the nucleus tractus solitarii (NTS; A2 neurons) and ventrolateral medulla (A1 neurons) represent gonadal steroid-dependent components of several neural networks regulating reproduction. Previous studies have shown that both A1 and A2 neurons express estrogen receptors (ERs). Using double labeling immunocytochemistry we report here that substantial numbers of NE neurons located within the NTS express progesterone receptor (PR) immunoreactivity, whereas few PRs are found in ventrolateral medulla. The evaluation of ER␣ and PR immunoreactivity in NE neurons through the estrous cycle revealed a fluctuating pattern of expression for both receptors within the NTS. The percentage of A2 neurons expressing PR immunoreactivity was low on metestrus and diestrus (3-7%), but increased significantly to approximately 24% on proestrous morning and remained at intermediate levels until estrus. The pattern of ER␣ immunoreactivity in A2 neurons was more variable, but a similar increment from 11% to 40% of NE neurons expressing ER␣ was found from diestrus to proestrus. Experiments in ovariectomized, estrogen-treated and estrogen-plus progesteronetreated rats revealed that PR immunoreactivity in A2 neurons was induced strongly by estrogen treatment, whereas progesterone had no significant effect. The numbers of ER␣-positive NE neurons were not influenced by steroid treatment. These observations provide direct evidence for PRs in NE neurons of the brainstem and show that cyclical patterns of gonadal steroid receptor expression exist in A2, but not A1, neurons through the rat estrous cycle. The expression of PR in A2 neurons appears to be driven principally by circulating estrogen concentrations. The fluctuating levels of ER␣ and PR expression in these brainstem NE neurons may help generate cyclical patterns of biosynthetic and electrical activity within reproductive neural networks. (Endocrinology 140: [3255][3256][3257][3258][3259][3260][3261][3262][3263] 1999) N OREPINEPHRINE (NE) neurons of the caudal brainstem are likely to play an important, gonadal steroid-dependent role in the control of reproductive activity (1-4). For example, NE is thought to be involved in mediating part of the stimulatory influence of estrogen and progesterone on the GnRH neurons, which do not themselves express detectable gonadal steroid receptors (5). Although it remains unclear whether NE terminals synapse directly upon GnRH cell bodies (4, 6), retrograde tracing experiments in rats (7, 8) have shown that NE inputs to the vicinity of the GnRH cell bodies in the preoptic area arise predominantly from the NE neurons located in the ventral lateral medulla (VLM; A1 neurons) and nucleus tractus solitarii (NTS; A2 neurons). These inputs have been shown to be functionally relevant in vivo, as the electrical stimulation of either cell group evokes the release of NE within the preoptic area (9) and also modulates pulsatile LH secretion (10, 11) . Similar LH responses are found with the manipulation of adrenergic receptor occupancy in the preoptic area, but not the mediobasal hypothalamus (12).
variable, but a similar increment from 11% to 40% of NE neurons expressing ER␣ was found from diestrus to proestrus. Experiments in ovariectomized, estrogen-treated and estrogen-plus progesteronetreated rats revealed that PR immunoreactivity in A2 neurons was induced strongly by estrogen treatment, whereas progesterone had no significant effect. The numbers of ER␣-positive NE neurons were not influenced by steroid treatment. These observations provide direct evidence for PRs in NE neurons of the brainstem and show that cyclical patterns of gonadal steroid receptor expression exist in A2, but not A1, neurons through the rat estrous cycle. The expression of PR in A2 neurons appears to be driven principally by circulating estrogen concentrations. The fluctuating levels of ER␣ and PR expression in these brainstem NE neurons may help generate cyclical patterns of biosynthetic and electrical activity within reproductive neural networks. (Endocrinology 140: [3255] [3256] [3257] [3258] [3259] [3260] [3261] [3262] [3263] 1999) N OREPINEPHRINE (NE) neurons of the caudal brainstem are likely to play an important, gonadal steroid-dependent role in the control of reproductive activity (1) (2) (3) (4) . For example, NE is thought to be involved in mediating part of the stimulatory influence of estrogen and progesterone on the GnRH neurons, which do not themselves express detectable gonadal steroid receptors (5) . Although it remains unclear whether NE terminals synapse directly upon GnRH cell bodies (4, 6) , retrograde tracing experiments in rats (7, 8) have shown that NE inputs to the vicinity of the GnRH cell bodies in the preoptic area arise predominantly from the NE neurons located in the ventral lateral medulla (VLM; A1 neurons) and nucleus tractus solitarii (NTS; A2 neurons). These inputs have been shown to be functionally relevant in vivo, as the electrical stimulation of either cell group evokes the release of NE within the preoptic area (9) and also modulates pulsatile LH secretion (10, 11) . Similar LH responses are found with the manipulation of adrenergic receptor occupancy in the preoptic area, but not the mediobasal hypothalamus (12) .
Early studies showing that NE turnover and content within the hypothalamus fluctuated in response to gonadal steroid manipulations (13) (14) (15) indicated that estrogen and progesterone may regulate the activity of NE neurons. Indeed, more recent studies have shown that gonadal steroids can regulate tyrosine hydroxylase as well as immediate early gene expression within the A1 and A2 neurons (16, 17) . Together with evidence for immediate early gene induction in A1 and A2 neurons on proestrus (17, 18) and increments in NE release within the preoptic area at a similar time (14, 19) , these observations support the hypothesis that the changing gonadal steroid environment alters NE signaling within the GnRH network to modulate the electrical and transcriptional activities of GnRH neurons (5) . The nature of gonadal steroid action on the A1 and A2 neurons of the rat is currently under investigation. In terms of estrogen, there is evidence for the presence of ER␣ within a distinct, topographically organized subpopulation of A1 and A2 neurons (20 -22) . The recent demonstration of ER␤ within the caudal medulla of the rat brainstem suggests that ER␤ may also be expressed in A1 and A2 neurons (23) . Thus, it would appear that estrogen has a direct route through which may it influence gene expression and possibly the electrical activity of A1 and A2 neurons. The situation for progesterone is much less clear. No studies have examined whether progesterone receptors (PRs) are expressed in the caudal brainstem, and it is not known whether A1 and A2 neurons synthesize PRs.
The first objective of the present series of studies was to examine whether PRs were expressed in NE neurons of the caudal brainstem. As gonadal steroid receptor expression within the brain is known to fluctuate across the estrous cycle (24, 25) and may thus represent a molecular event involved in the cyclical activity within neural networks, the second objective of our studies was to examine the profile of ER␣ and PR expression in A1 and A2 neurons throughout the cycle. Finally, to assess the influence that estrogen and progesterone may exert on ER and PR expression in NE neurons, we have also determined ER␣ and PR immunoreactivity in the NE neurons of ovariectomized female rats treated with gonadal steroids.
Materials and Methods

Experimental animals
Female Wistar rats were maintained in a light-and temperaturecontrolled environment (12-h light, 12-h dark cycle, with lights on at 0600 h), with food and water freely available. All animal procedures were carried out in accordance with the animals experimentation committee of the Agricultural University of Wageningen and the United Kingdom Home Office regulations. Animals showing regular 4-day estrous cycles were killed on the morning of estrus, metestrus, diestrus, or proestrus (1000 h) and additionally on the afternoon (1600 h) of diestrus and proestrus (n ϭ 4 -6 at each stage). Animals were anesthetized with Nembutal (0.1 ml/100 g BW, ip) and perfused transcardially with saline followed by 4% paraformaldehyde in phosphate buffer, then postfixed for 1-2 h in the same fixative at room temperature. Brains were cryoprotected by immersion in a 30% sucrose solution and then stored at Ϫ80 C.
Another group of animals was used to evaluate the effects of estrogen and progesterone treatment on ER␣ and PR immunoreactivity in brainstem NE neurons. Virgin female Wistar rats were ovariectomized under Avertin anesthesia (2% tribromoethanol and 1% amyl alcohol, 1 ml/100 g BW, ip) 7-10 days before steroid treatment. Animals were given one of three treatments: 1) oil, single injections of vehicle (100 l ethyl oleate, sc; Fluka, Buchs, Germany) administered at 1030 h on each of the 2 days before perfusion (n ϭ 4); 2) estradiol benzoate (EB; 5 g in 100 l ethyl oleate, sc; Sigma Chemical Co., Poole, UK) administered at 1030 h on each of the 2 days before perfusion (n ϭ 6); and 3) single injections of EB administered as in group 2 and an injection of progesterone (0.5 mg in 100 l ethyl oleate; Sigma Chemical Co.) administered at 1030 h on the day before perfusion (n ϭ 7). Previous work with ovariectomized rats in this laboratory (26, 27) has shown that EB administered in this manner suppresses LH secretion, and progesterone treatment for 27 h has been shown by others to decrease PR messenger RNA (mRNA) expression within the hypothalamus (24) . Animals were anesthetized between 1000 -1400 h with Avertin (1.5 ml/100 g BW, ip) and perfused transcardially with heparinized saline followed by 4% paraformaldehyde in phosphate buffer, then postfixed for 1-2 h in the same fixative at room temperature. Brains were cryoprotected by immersion in a 30% sucrose solution overnight.
Single labeling PR and ER␣ immunocytochemistry
Three sets of coronal brainstem sections (30 m thick) containing the NTS and VLM were cut using a freezing microtome. All sections were subjected to immunocytochemistry following a previously detailed procedure (21) . In brief, after washing in a 40% methanol-0.05 m Trisbuffered saline (TBS) solution containing 1% H 2 O 2 , one set of free floating sections underwent immunocytochemistry for the PR. Sections were incubated in a polyclonal rabbit antibody, directed against the DNAbinding domain (amino acids 533-547) of the human progesterone receptor (1:1000; DAKO Corp., Glostrup, Denmark) for 72 h at 4 C. This was followed by biotinylated goat antirabbit Igs (1:200; Vector Laboratories, Inc., Peterborough, UK) and the Vectastain Elite conjugate (1:100; Vector Laboratories, Inc.) for 90 min each at room temperature.
For ER␣ immunocytochemistry, an additional set of sections was incubated in a monoclonal mouse antibody directed against the Nterminal domain of the human ER␣ (ID5; 1:10; gift from G. Delsol, Toulouse, France; available from DAKO Corp.) for 72 h at 4 C. This was followed by biotinylated horse antimouse Igs (1:200; Vector Laboratories, Inc.) and the Vectastain Elite avidin-peroxidase conjugate (1:00; Vector Laboratories, Inc.) for 90 min each at room temperature. Immunoreactivities for both PR and ER␣ were visualized using the glucose oxidase nickel-enhanced 3,3Ј-diaminobenzidine tetrahydrochloride (DAB) technique to yield a black reaction product.
Double labeling immunocytochemistry
Sections that had undergone immunocytochemistry for PR or ER␣ were then processed for double labeling immunocytochemistry by washing sections in a 40% methanol-TBS solution containing 1% H 2 O 2 and incubating them in a monoclonal mouse antityrosine hydroxylase (anti-TH) antibody (1:4000; MAB 318, Chemicon, Harrow, UK) for 72 h at 4 C. Pilot experiments comparing dual labeling of sections with the PR antibody and either this TH antibody or a polyclonal rabbit antiserum raised against dopamine-␤-hydroxylase demonstrated that the former combination was superior. The TH antibody incubation was followed by biotinylated horse antimouse Igs (1:200; Vector) and the streptavidin horseradish peroxidase complex (SABC 1:200; Amersham, Aylesbury, UK), each for 90 min at room temperature. TH immunoreactivity was visualized using DAB alone to yield a brown reaction product. All antibodies were diluted in TBS containing 0.25% BSA and 0.3% Triton X-100. Vector Elite and SABC were diluted in TBS alone. Sections were coverslipped with DPX (BDH, Poole, UK) before analysis on a Leica Corp. DM-RB microscope at ϫ10 -40 objective magnification.
Antibody specificity and control experiments
The production and specificity of the polyclonal rabbit PR antibody raised against the human PR has been described previously (25, 28, 29) . Liquid phase adsorption control experiments were performed by overnight incubation of the PR antibody at 4 C with a 100 g/ml concentration of the PR peptide used as antigen (amino acids 533-547; Genosys Biotechnologies, Inc., The Woodlands, TX). Sections incubated with preadsorbed antibody revealed no nuclear immunoreactivity. The production and specificity of the ID5 and TH antibodies for use in the rat brainstem have been reported previously (21) . Omission of the primary ER␣ or PR antibody resulted in the absence of nuclear immunostaining, and in control experiments undertaken using the double labeling procedure, no cytoplasmic immunoreactivity was detected after omission of the TH antibody.
Analysis
The analysis of single and double labeled cells was undertaken in brainstem sections extending from the caudal to the rostral medulla by an investigator unaware of the experimental groups. Coronal brainstem sections were subdivided as previously described (21) on a cytoarchitectural basis into three different rostrocaudal levels: 1) rostral: immediately rostral to the area postrema (AP Ϫ13.6 to Ϫ14.2); 2) middle: area containing and immediately caudal to the area postrema (AP Ϫ14.2 to Ϫ14.8); and 3) caudal: midway between the area postrema and the caudal medulla where the dorsal column fasciculae overlie the beginning of the NTS (AP Ϫ14.8 to Ϫ15.5), corresponding to plates 68 -69, 70 -71, and 72-73, respectively, of Swanson (30) and represented in Fig. 1 . In each rat and for all analyses, cell profile counts were obtained from a minimum of six sections at each of the three levels. In the case of the NTS, all immunoreactive cells within its boundaries were counted bilaterally, whereas analysis of the VLM was undertaken on a hemisection basis to ensure the correct rostrocaudal grouping of cells. In double labeled sections all nickel-and DAB-stained nuclear profiles, brown DAB-stained cytoplasmic profiles with nuclear exclusions, and double labeled cells exhibiting black nuclei and a brown cytoplasm were counted. Individual values from animals were combined to provide the mean at each level, and these were used to determine the group mean Ϯ sem in all cases. In cycling animals, we were interested in defining differences between temporally contiguous groups and accordingly performed sequential Mann-Whitney tests. In the gonadal steroid treatment experiments, multiple cross-comparisons were made, and statistical analysis was performed using ANOVA followed by post-hoc Student-NewmanKeuls tests.
Results
TH immunoreactivity through the estrous cycle
Neurons immunoreactive for TH were found clustered in the NTS (A2 cells) and the VLM (A1 cells) of the caudal medulla ( Fig. 1) as described previously (21, 31) . No significant changes in the number of TH neurons were detected in either the NTS or the VLM through the estrous cycle (Tables  1 and 2 ). As reported previously (21) , the maximum number of TH-immunoreactive cells found were in the middle division of the NTS, although substantial numbers were also seen in the rostral and caudal sections (Tables 1 and 2 ). Numerous TH-immunoreactive cells were also detected within the VLM, although no rostro-caudal differences in their distribution were evident (Tables 1 and 2 ).
PR immunoreactivity in the NTS and VLM through the estrous cycle
Substantial numbers of PR-expressing cells (5-15 cells/ section) were detected in the middle and caudal levels of the NTS, where they extended laterally to the boundaries of the NTS (Table 1 and Fig. 1 ). Cells exhibiting PR immunoreactivity were also found at much lower density within the area postrema, the caudal aspect of the spinal nucleus of the trigeminal nerve, and along the ventral aspect of the brainstem (Fig. 1) . Compared with the NTS, very few PR-immunoreactive cells were detected in the VLM (Table 1 ). The number of PR-immunoreactive cells encountered in the middle and caudal sections of the NTS changed significantly during the estrous cycle, when an increase was found from the lowest level of expression on the afternoon of diestrus to maximal expression on the morning of proestrus (P Ͻ 0.05) in both middle and caudal divisions of the NTS ( Table 1 ). The very low numbers of PR-immunoreactive cells detected in the VLM precluded any similar statistical analysis.
PR immunoreactivity in A1 and A2 norepinephrine neurons through the estrous cycle
The great majority of double labeled cells displaying brown cytoplasmic staining for TH and black nuclear staining for PR (Fig. 2) were found within the middle and caudal levels of the NTS (Table 1 and Figs. 1 and 3 ). Very few (less than one cell per section) double labeled A2 neurons were found in the more rostral sections (Table 1) , whereas A1 neurons displaying PR immunoreactivity were rare and were only detected in the most caudal sections (Table 1) . Neurons staining for TH accounted for 30 -50% of all PRimmunoreactive cells identified in the NTS (Table 1) .
The profile of PR immunoreactivity in A2 neurons within the middle and caudal levels of the NTS, where most TH-PR dual labeled cells are found, changed significantly over the course of the estrous cycle ( Fig. 3 and Table 1 ). The number (Table 1) and percentage ( Fig. 3 ) of middle division A2 neurons with PR immunoreactivity was lowest (0.6 cells/section or 3% of all A2 cells) on diestrous morning, but rose significantly (P Ͻ 0.05) on proestrous morning (6.3 cells/section, or 24%) to reach a peak before declining on proestrous afternoon (4 cells/section, or 14%; Fig. 3) . A similar temporal pattern was seen in the caudal region (Fig. 3) , with a significant (P Ͻ 0.05) increase in the percentage of A2 cells exhibiting PR staining occurring from the afternoon of diestrus (1%) to proestrous morning (21%). At this rostrocaudal level, PR immunoreactivity in A2 cells remained at an intermediate level of around 10% even during metestrous and diestrous morning (Fig. 3) . The same trend was apparent in the rostral division of the A2 (Fig. 3) , but very few double labeled cells were encountered at this level.
ER␣ immunoreactivity in A1 and A2 norepinephrine neurons through the estrous cycle
The distribution of ER␣ immunoreactivity within the caudal medulla was the same as that reported previously (21) . Compared to PR staining, the numbers of ER␣-immunoreactive cells encountered per section in the NTS were greater at essentially all levels examined (Table 2) , and additional FIG. 1. Camera lucida diagrams of single and double labeled cells exhibiting TH and PR immunoreactivity at three AP levels of the caudal brainstem in a proestrous morning rat; rostral (Ϫ13.8), middle (Ϫ14.4), and caudal (Ϫ15.5) from the bregma, according to Swanson (30) . Large triangles denote three to five TH-immunoreactive neurons, whereas small triangles represent one or two neurons. ap, Area postrema; ecu, cuneate nucleus; g, gracile nucleus; spvc, caudal part of the spinal nucleus of the trigeminal nerve; xii, hypoglossal nerve.
populations of ER␣-immunoreactive cells were identified throughout the VLM, in the reticular nuclei, and within the lateral boundaries of the caudal spinal nucleus of the trigeminal nerve. Again, as reported previously (21), a clear rostro-caudal topography existed in terms of ER␣ immunoreactivity within the A1 and A2 neurons, with the highest density of ER␣-expressing NE neurons being detected in the caudal level of the NTS and VLM (Table 2) .
Temporal changes in ER␣ immunoreactivity also occurred during the estrous cycle (Table 2) . Despite a substantial degree of variability between animals, a significant increase in the number of ER␣-expressing neurons was encountered between diestrous afternoon and proestrous morning within the caudal NTS (P Ͻ 0.05; Table 2 ). This change was also reflected in a significant increase (P Ͻ 0.05) in the numbers (Table 2 ) and percentage (Fig. 3 ) of A1 and A2 neurons found to express ER␣ immunoreactivity between these 2 days in the caudal and middle divisions of the NTS. However, as with the total number of ER␣-immunoreactive cells encountered, the number of double labeled cells also varied markedly between animals and resulted in relatively high levels of ER␣ expression in A2 neurons that did not change significantly across the cycle at other times (Fig. 3) . We found no evidence for changing patterns of ER␣ immunoreactivity within A1 neurons during the estrous cycle (Table 2) .
PR and ER␣ immunoreactivity in the brainstem in response to gonadal steroid manipulation
The distribution of PR, ER␣, and TH immunoreactivity within the caudal medulla of ovariectomized control and gonadal steroid-treated rats was exactly the same as that described above for intact animals. The numbers of THimmunoreactive cells detected at the three different levels in the NTS and VLM were not different in the three treatment groups. The total number of PR-immunoreactive cells detected in the caudal level of the NTS was increased after the administration of estrogen to ovariectomized rats (P Ͻ 0.05), Mean numbers (ϮSEM) of PR, TH, and double labeled immunoreactive cells counted per section in the NTS and per hemisection in the VLM at three rostro-caudal levels during the estrous cycle. M, Metestrus; D, diestrus; P, proestrus; E, estrus. The most rostral level is AP Ϫ13.6; the most caudal is AP Ϫ15.5, and the area postrema is found at AP Ϫ14.2. Different letters between temporally contiguous groups indicate a significant difference (P Ͻ 0.05, by Mann-Whitney test; n ϭ 4/5). Mean number (ϮSEM) of ER␣, TH, and double labeled immunoreactive cells counted per section in the NTS and per hemisection in the VLM at three rostro-caudal levels during the estrous cycle. M, Metestrus; D, diestrus; P, proestrus; E, estrus. The most rostral level is AP Ϫ13.6, the most caudal is AP Ϫ15.5, and the area postrema is at AP Ϫ14.2. A change in letter between temporally contiguous groups indicates a significant difference (P Ͻ 0.05, by Mann-Whitney test; n ϭ 4/5).
whereas the number of ER␣-immunoreactive cells did not change (Table 3) . No differences in the number of PR-or ER␣-immunoreactive cells were detected after progesterone administration to estrogen-treated ovariectomized rats. The numbers of ER␣-and PR-expressing neurons in the VLM did not change in response to either of the gonadal steroid manipulations (Table 3 ).
An analysis of the numbers (Table 3 ) and percentage (Fig.  4) of dual labeled A2 neurons in estrogen-treated ovariectomized rats revealed a strong induction of PR immunoreactivity in NE neurons of the middle and caudal NTS after estrogen treatment. For example, in the caudal NTS, the number of A2 neurons with PR staining increased from approximately 2 to nearly 10 cells/section (Table 3) , and this represented an increase from 10% of all A2 neurons in ovariectomized rats to proestrus-like levels of around 30% of all A2 cells after estrogen treatment (Fig. 4) . No changes were detected in the low numbers of PR-expressing A1 neurons (Table 3) . Progesterone treatment had no effect on the number of PR-immunoreactive A1 or A2 neurons (Fig. 4 and Table 3 ).
The number (Table 3 ) and percentage (Fig. 4 ) of NTS and VLM neurons found to express ER␣ immunoreactivity were not influenced by gonadal steroid treatment.
Discussion
We report here the first description of PR-expressing cells within the brainstem. The PR antibody used in these studies is known to label cells in the developing and adult hypothalamus (25, 29) with a distribution identical to that shown previously with radioactive PR autoradiography (32) and PR mRNA in situ hybridization (24, 33) in the rat. The use of dual labeling immunocytochemistry has enabled us to show the presence of PR immunoreactivity in up to 30% of THcontaining neurons located in the NTS. Although a small population of TH cells within the NTS is known to be dopaminergic, the vast majority of TH cells in the NTS and all TH cells in the VLM represent NE neurons (21, 31) . Thus, we believe that the present findings provide convincing evidence for the expression of PRs in brainstem NE neurons of the rat. This is confirmed by the recent preliminary report of dual labeled PR mRNA and TH mRNA-expressing cells within the caudal brainstem of the rat (34) . We also believe that potential aqueous fixation artifacts resulting from the different bound or unbound states of the PR and ER within the cell are unlikely to be of concern in this study, as the administration of progesterone did not alter PR immunoreactivity and, equally, estrogen did not influence ER staining in the brainstem.
One surprising aspect of the distribution of PR-immunoreactive cells within the caudal brainstem has been the relative scarcity of labeled cells within the VLM and, specifically, the A1 neurons. This observation was made in all animals regardless of their endocrine state and suggests that little PR is synthesized by A1 neurons at any time of the estrous cycle. This is noteworthy, as ER␣-expressing A1 neurons are plentiful, especially in the most caudal brainstem (21) . Together, this would suggest that the A1 neurons may be a further example of a small group of neurons that expresses ERs but not PRs (35, 36) . In contrast, the PR expression by A2 neurons paralleled that of ER␣ immunoreactivity, with a clear rostrocaudal topography in gonadal steroid receptor expression within the brainstem. Thus, very few A2 neurons located in the rostral part of the NTS express ERs or PRs, whereas approximately 40% and 20% of A2 neurons in the caudal medulla contain ER␣ and PR immunoreactivity, respectively.
In terms of the ER␣-and PR-expressing cell populations of the NTS, our studies indicate that at least 50% are not synthesizing dopamine or NE. Relatively little is known about the neurochemical identity of these other steroid-receptive cells, but preliminary work (Simonian, S. X., and A. E. Herbison, unpublished observations) shows that up to 20% of ER␣-expressing neurons in the NTS contain the neuropeptide somatostatin. Furthermore, there appears to be a high degree of neurochemical organization in the projections of ER-expressing NTS neurons; whereas 90% of ER-containing neurons projecting to the rostral preoptic area synthesize NE (4), none of the ER-containing neurons projecting to the supraoptic nucleus contain NE (37).
Although we have not proven that A2 neurons express both ER␣ and PR receptors, we note that the number of NE neurons with PRs was approximately half the number found to express ER␣ at each level of the NTS in cycling rats. This along with evidence for the induction of PRs exclusively in cells with ERs (35, 36) suggest that up to half of estrogenreceptive A2 neurons synthesize PRs. Interestingly, the one exception to this situation was after estrogen treatment of ovariectomized rats, when approximately 20% of "middle" A2 neurons expressed PR, whereas only 10% were found to be immunoreactive for ER␣. Whether the remaining 10% of PR-expressing A2 neurons contain ER␤ is not known. If these A2 neurons were found to possess neither ER, they would represent an interesting case of ER-independent activation of PR expression by estrogen.
The ability of estrogen to directly up-regulate PR gene expression within the hypothalamus is well established (33, 35, 36) , although it remains undecided whether this involves ER␣, ER␤, or both of these transcription factors (38, 39) . Our present results demonstrate that estrogen also induces PR expression within the A2 neurons of the brainstem and indicate that estrogen is likely to underlie the induction of PR immunoreactivity in these cells on proestrous morning. It is noteworthy that we have identified a rather abrupt increase in PR expression within A2 neurons on proestrous morning despite the fact that estrogen concentrations rise gradually throughout diestrus and proestrus. One explanation for the abrupt increase in PR may be that a threshold level of estrogen is required to activate PR gene transcription and/or that a delay may exist in the translation of PR transcripts in A2 neurons. Alternatively, it may be that an inhibitory influence of postovulatory progesterone secretion counterbalances the stimulatory effect of rising estrogen levels in diestrus. Against this latter hypothesis, however, is our evidence that 24 -27 h of progesterone treatment upon an estrogen background did not alter PR immunoreactivity in A2 neurons. Further work will be required to examine this issue.
Somewhat surprisingly, we found little direct evidence for the gonadal steroid regulation of ER␣ immunoreactivity in brainstem NE neurons. Previous studies within the hypothalamus have shown that ER␣ mRNA expression is downregulated by estrogen (24, 40) , whereas we detected no changes in ER immunoreactivity within either A1 or A2 neurons after estrogen administration to ovariectomized rats. Furthermore, we found a significant increase, rather than a decrease, in the number ER␣-expressing A1 and A2 neurons on proestrous morning when circulating estrogen concentrations are rising. There is good evidence for the region-specific regulation of ER gene expression in the brain (41) , and it would appear that the regulation of ER␣ within brainstem NE neurons may be distinct from that occurring within hypothalamic cells.
A number of studies have shown that the biosynthetic and electrical activities of brainstem NE neurons are influenced by gonadal steroids. Thus, estrogen has been demonstrated to increase immediate early gene expression in A2 neurons (17) as well as the spontaneous firing rate of A1 neurons (42) , and this may underlie the elevated NE turnover in the hypothalamus after estrogen treatment (13) (14) (15) . It has been suggested that estrogen acts principally through the A2 neurons to enhance the diurnal variation in NE release within the hypothalamus (4). Although we encountered substantial interanimal variability in the pattern of ER␣ expression within A1 and A2 neurons, it is of note that the lowest levels of ER␣ expression by A2 neurons were in the two groups of animals killed in the afternoon. This observation raises the intriguing possibility that a pattern of steroid-independent, diurnal ER␣ expression occurs in brainstem NE neurons.
Much less data are available in terms of progesterone's influence on brainstem NE neurons. The release of NE in the ventromedial nucleus (43) and median eminence (15) is elevated by acute progesterone treatment, whereas progesterone exposure for 24 h is thought to antagonize estrogen's stimulatory actions on NE release throughout the hypothalamus (44) . Our observation here of PRs expressed predominantly within A2 rather than A1 neurons indicates that any direct genomic influences of progesterone on NE signaling within the hypothalamus arise from these NTS neurons. The induction of PRs in A2 neurons on proestrous morning would enable the rising progesterone levels later that day to alter gene expression and, thus, the behavior of the subpopulation of A2 neurons with PRs. However, the complete absence of data on the molecular effects of progesterone on NE neurons makes it impossible to determine whether direct genomic actions of progesterone in A2 neurons may be responsible for acutely enhancing and/or chronically repressing their activity.
The gonadal steroid-dependent changes in brainstem NE neurons are likely to have a permissive role in the regulation of GnRH secretion and biosynthesis (5) . Retrograde labeling experiments from the rostral preoptic area have highlighted the importance of the A1 and A2 neurons with respect to the cell bodies of the GnRH neurons (8) , and triple labeling studies have gone on to show that it is exclusively the A2 neuronal afferents that express ER␣ (45) . The finding here that PRs are only found to any substantial degree in A2 neurons highlights further the potential importance of these cells in gonadal steroid signaling to the GnRH neurons. We also have preliminary evidence that PR-expressing A2 neurons project to the vicinity of the GnRH cell bodies in the rostral preoptic area (Haywood, S. A., et al., unpublished observations). Thus, evidence exists for both ER-and PRexpressing A2 neurons that project to the vicinity of the GnRH neurons as well as for the induction of both ovarian steroid receptors in A2 neurons on the morning of proestrus. These observations further support the hypothesis that the rising titers of estrogen during the cycle may modulate NE transmission directed at the GnRH neurons to facilitate the increase in GnRH biosynthesis and secretion that occurs at this time (5) . Equally, the induction of PR expression within these neurons in early proestrus may occur in readiness for the rise in progesterone concentrations later that day and/or be involved in the ligand-independent activation of gene expression (46) in A2 neurons. In this sense, subpopulations of A2 cells may provide a neural substrate within the GnRH Mean number (ϮSEM) of PR or ER␣ and double labeled cells counted per section in the NTS and per hemisection in the VLM at three rostro-caudal levels, after estrogen (EB) or estrogen and progesterone (EB ϩ P) treatment compared with that in oil-treated ovariectomized control rats. The most rostral level is AP Ϫ13.6, the most caudal level is AP Ϫ15.5, and the area postrema is at AP Ϫ14.2. A change in letter between temporally contiguous groups indicates a significant difference. Different letters indicate significant differences (P Ͻ 0.05) by ANOVA with post-hoc Student-Newman-Keuls test (n ϭ 6/7). network where coordinated PR-and ER-regulated gene expression occurs.
In summary, we show here that many NE neurons in the NTS express PRs and that the pattern of PR immunoreactivity in these neurons fluctuates through the estrous cycle; a marked, and probably estrogen-dependent, induction of PR expression was found to occur on proestrous morning. The expression of ER␣ immunoreactivity in A2 neurons was also found to increase significantly on proestrous morning, although little evidence was found for gonadal steroid regulation of ER␣ expression within brainstem NE neurons. These changes in gonadal steroid receptor expression within the A2 neurons, in particular, may represent molecular events that underlie the ability of estrogen and progesterone to alter NE transmission within the hypothalamus and elsewhere in the brain.
